Patients with insulin will face higher prices and lower quality care as a result of Democrats’ socialized drug price controls, Ways and Means Republican Rep. Kevin Hern (R-OK) writes in an op-ed for the Daily Signal.
“Despite its promising name, this legislation is just another example of Washington false advertising. No matter what words President Biden and Democrats in Washington use, the Inflation Reduction Act won’t deliver as promised, and ...
“Make no mistake – this massive spending bill will raise energy costs, kill innovation for future health cures, diminish opportunities for American jobs, harm small businesses and raise taxes,” Ways and Means Republican Rep. Darin Lahood (R-IL)
Lower- and middle-income earning Americans are the primary target in the IRS expansion in Democrats’ Manchin-Biden bill, which will unleash 87,000 new agents to increase audits on American taxpayers. New analysis from the nonpartisan ...
Democrats’ Manchin-Biden Build Back Better paves the way for more audits on hard-working taxpayers instead of offering relief for American families struggling with inflation, Republican Leader on the Trade Subcommittee Rep. Adrian Smith (R-TX) writes in an op-ed for Fox News. Democrats rejected Republican efforts to safeguard low- and middle- income taxpayers from ...
“It is obvious that adding new taxes would harm an already weakened economy and stretch family budgets to the breaking point,” warned Republican Leader of the House Committee on Budget and Ways and Means Member Rep. Jason Smith (R-MO) in a
The Biden Administration claimed that accelerating progress towards curing cancer was a priority, yet the new Manchin-Biden Build Back Better bill is a surrender in the fight against cancer. It ...
It’s time for the Biden Administration to work with Republicans to promote American innovation and ensure our businesses compete and win in the global economy, Republican Leader on the Ways and Means Health Subcommittee Rep. ...
Democrats drove the economy into a recession and the new Schumer-Manchin
As Senate Democrats make their final push for a socialist prescription drug pricing legislation that endangers new treatments and cures, Republican on the Ways and Means Committee Rep. Brad Wenstrup (R-OH)